Similarly, in colon cancer, IGF2BP3 has been identified as a regulator of vascular endothelial growth factor (VEGF) mRNA stability via m6A modification, facilitating tumor angiogenesis (Yang et al., 2020). Here, IGF2BP3 is linked to neoplasm.